Monocarboxylate Transporter 4 and Caveolin-1 Expression in Squamous Cell Carcinoma of the Oral Cavity

Authors

Julie A. Ames, MD, Thomas Jefferson UniversityFollow
Aileen Butera, MD, Thomas Jefferson University
Joseph Curry, MD, Thomas Jefferson UniversityFollow
Madalina Tuluc, MD, Thomas Jefferson UniversityFollow
Ubaldo E. Martinez-Outshoorn, MD, Thomas Jefferson UniversityFollow
Diana Whitaker-Menezes, PhD, Thomas Jefferson UniversityFollow
Federica Sotgia, PhD, Thomas Jefferson UniversityFollow
Michael P. Lisanti, MD, PhD, Thomas Jefferson UniversityFollow

Document Type

Poster

Publication Date

7-22-2012

Abstract

Poster presented at: 8th International Conference on Head and Neck Cancer in Toronto Canada, July 21-25, 2012.

Objective: To determine the significance of caveolin-1 (cav-1) and monocarboxylate transporter 4 (MCT4) in squamous cell carcinoma of the oral cavity. We hypothesized that high stromal MCT4 would predict a worse prognosis and correlate with low stromal Cav-1.

Recommended Citation

Ames, MD, Julie A.; Butera, MD, Aileen; Curry, MD, Joseph; Tuluc, MD, Madalina; Martinez-Outshoorn, MD, Ubaldo E.; Whitaker-Menezes, PhD, Diana; Sotgia, PhD, Federica; and Lisanti, MD, PhD, Michael P., "Monocarboxylate Transporter 4 and Caveolin-1 Expression in Squamous Cell Carcinoma of the Oral Cavity" (2012). Department of Otolaryngology - Head and Neck Surgery Faculty Papers. Poster 18.
https://jdc.jefferson.edu/otofp/18